Literature DB >> 26657404

Changes in Whole-Body Oxygen Consumption and Skeletal Muscle Mitochondria During Linezolid-Induced Lactic Acidosis.

Alessandro Protti1, Dario Ronchi, Gabriele Bassi, Francesco Fortunato, Andreina Bordoni, Tommaso Rizzuti, Roberto Fumagalli.   

Abstract

OBJECTIVE: To better clarify the pathogenesis of linezolid-induced lactic acidosis.
DESIGN: Case report.
SETTING: ICU. PATIENT: A 64-year-old man who died with linezolid-induced lactic acidosis.
INTERVENTIONS: Skeletal muscle was sampled at autopsy to study mitochondrial function.
MEASUREMENTS AND MAIN RESULTS: Lactic acidosis developed during continuous infusion of linezolid while oxygen consumption and oxygen extraction were diminishing from 172 to 52 mL/min/m and from 0.27 to 0.10, respectively. Activities of skeletal muscle respiratory chain complexes I, III, and IV, encoded by nuclear and mitochondrial DNA, were abnormally low, whereas activity of complex II, entirely encoded by nuclear DNA, was not. Protein studies confirmed stoichiometric imbalance between mitochondrial (cytochrome c oxidase subunits 1 and 2) and nuclear (succinate dehydrogenase A) DNA-encoded respiratory chain subunits. These findings were not explained by defects in mitochondrial DNA or transcription. There were no compensatory mitochondrial biogenesis (no induction of nuclear respiratory factor 1 and mitochondrial transcript factor A) or adaptive unfolded protein response (reduced concentration of heat shock proteins 60 and 70).
CONCLUSIONS: Linezolid-induced lactic acidosis is associated with diminished global oxygen consumption and extraction. These changes reflect selective inhibition of mitochondrial protein synthesis (probably translation) with secondary mitonuclear imbalance. One novel aspect of linezolid toxicity that needs to be confirmed is blunting of reactive mitochondrial biogenesis and unfolded protein response.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26657404     DOI: 10.1097/CCM.0000000000001478

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

Review 1.  Linezolid Administration to Critically Ill Patients: Intermittent or Continuous Infusion? A Systematic Literature Search and Review.

Authors:  Ligia-Ancuta Hui; Constantin Bodolea; Laurian Vlase; Elisabeta Ioana Hiriscau; Adina Popa
Journal:  Antibiotics (Basel)       Date:  2022-03-24

Review 2.  Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.

Authors:  Claire Roger; Jason A Roberts; Laurent Muller
Journal:  Clin Pharmacokinet       Date:  2018-05       Impact factor: 6.447

3.  Lactic Acidosis Induced by Linezolid Mimics Symptoms of an Acute Intracranial Bleed: A Case Report and Literature Review.

Authors:  Nichole Suzzanne Zuccarini; Tariq Yousuf; Daniel Wozniczka; Anis Abdul Rauf
Journal:  J Clin Med Res       Date:  2016-08-30

Review 4.  Understanding and Exploiting the Effect of Tuberculosis Antimicrobials on Host Mitochondrial Function and Bioenergetics.

Authors:  Christina Cahill; James Joseph Phelan; Joseph Keane
Journal:  Front Cell Infect Microbiol       Date:  2020-09-15       Impact factor: 5.293

5.  Incidence and Associated Risk Factors for Lactic Acidosis Induced by Linezolid Therapy in a Case-Control Study in Patients Older Than 85 Years.

Authors:  Tingting Liu; Chao Hu; Jionghe Wu; Miao Liu; Yifan Que; Jiang Wang; Xiangqun Fang; Guogang Xu; Hongxia Li
Journal:  Front Med (Lausanne)       Date:  2021-02-25

Review 6.  The risk factors of linezolid-induced lactic acidosis: A case report and review.

Authors:  Yiyang Mao; Danping Dai; Haiying Jin; Yangyang Wang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.